Mehra Anand

Director at Spark Therapeutics, Inc.; Director at ACRS; Director at AERIE PHARMACEUTICALS INC

Sold, on record
$171M
Dollars the filings state
Form 4 sales
22
Latest Jul 24, 2017
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Spark Therapeutics, Inc.Plan not stated
    Feb 7 2017

    Sold 25,334 shares at $65.06 ($1.6M)

    Mehra Anand, Director

    Sold 2.8% of holdings ($58.9M position)879,652 shares left1x usual sizeFiling

  2. 2 Form 4 sale Spark Therapeutics, Inc.Plan not stated
    Feb 9 +2 days

    Sold 37,411 shares at $65.06 ($2.4M)

    Mehra Anand, Director

    Sold 4.3% of holdings ($57.2M position)842,241 shares left1.5x usual sizeFiling

  3. 3 Form 4 sale Spark Therapeutics, Inc.Plan not stated
    Feb 16 +7 days

    Sold 35,347 shares at $65.03 ($2.3M)

    Mehra Anand, Director

    Sold 4.2% of holdings ($54.8M position)806,894 shares left1.3x usual sizeFiling

  4. 4 Form 4 sale Spark Therapeutics, Inc.Plan not stated
    Feb 17 +1 day

    Sold 7,535 shares at $65.01 ($490k)

    Mehra Anand, Director

    Sold 0.9% of holdings ($52.5M position)799,359 shares left0.3x usual sizeFiling

  5. 5 Form 4 sale Spark Therapeutics, Inc.Unusual
    Mar 1 +12 days

    Sold 84,654 shares at $65.02 ($5.5M)

    Mehra Anand, Director

    Sold 10.6% of holdings ($52M position)714,705 shares left3.1x usual sizeFiling

  6. 6 Form 4 sale Spark Therapeutics, Inc.Plan not stated
    Mar 2 +1 day

    Sold 15,275 shares at $65.01 ($993k)

    Mehra Anand, Director

    Sold 2.1% of holdings ($46.5M position)699,430 shares left0.5x usual sizeFiling

  7. 7 Form 4 sale Spark Therapeutics, Inc.Plan not stated
    Jun 21 +111 days

    Sold 6,302 shares at $65.00 ($410k)

    Mehra Anand, Director

    Sold 0.9% of holdings ($45.5M position)693,128 shares left0.2x usual sizeFiling

  8. 8 Form 4 sale Spark Therapeutics, Inc.Unusual
    Jul 24 +33 days

    Sold 211,858 shares at $70.15 ($14.9M)

    Mehra Anand, Director

    Sold 30.6% of holdings ($48.6M position)481,270 shares left8.4x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (22)

Form 144 notices and Form 4 sales by Mehra Anand
Source
Jul 24, 2017Spark Therapeutics, Inc.DirectorForm 4 sale211,858$14.9M30.6%UnusualSEC
Jun 21, 2017Spark Therapeutics, Inc.DirectorForm 4 sale6,302$410k0.9%Plan not statedSEC
Mar 2, 2017Spark Therapeutics, Inc.DirectorForm 4 sale15,275$993k2.1%Plan not statedSEC
Mar 1, 2017Spark Therapeutics, Inc.DirectorForm 4 sale84,654$5.5M10.6%UnusualSEC
Feb 17, 2017Spark Therapeutics, Inc.DirectorForm 4 sale7,535$490k0.9%Plan not statedSEC
Feb 16, 2017Spark Therapeutics, Inc.DirectorForm 4 sale35,347$2.3M4.2%Plan not statedSEC
Feb 9, 2017Spark Therapeutics, Inc.DirectorForm 4 sale37,411$2.4M4.3%Plan not statedSEC
Feb 7, 2017Spark Therapeutics, Inc.DirectorForm 4 sale25,334$1.6M2.8%Plan not statedSEC
Jan 10, 2017ACRSDirectorForm 4 sale750,000$21.2M32.8%UnusualSEC
Dec 16, 2016Spark Therapeutics, Inc.DirectorForm 4 sale349,656$18.7M27.9%UnusualSEC
Dec 13, 2016Spark Therapeutics, Inc.DirectorForm 4 sale122,532$6.8M8.9%UnusualSEC
Aug 11, 2016Spark Therapeutics, Inc.DirectorForm 4 sale29,963$1.8M2.1%Plan not statedSEC
Aug 8, 2016Spark Therapeutics, Inc.DirectorForm 4 sale100$6k0.0%Plan not statedSEC
Aug 4, 2016Spark Therapeutics, Inc.DirectorForm 4 sale5,064$304k0.4%Plan not statedSEC
Aug 1, 2016Spark Therapeutics, Inc.DirectorForm 4 sale22,665$1.4M1.6%Plan not statedSEC
May 31, 2016Spark Therapeutics, Inc.DirectorForm 4 sale500$30k0.0%Plan not statedSEC
Nov 27, 2015Spark Therapeutics, Inc.DirectorForm 4 sale22,961$1.4M1.6%Plan not statedSEC
Nov 12, 2015Spark Therapeutics, Inc.DirectorForm 4 sale130,605$7.9M8.2%Plan not statedSEC
Oct 8, 2015Spark Therapeutics, Inc.DirectorForm 4 sale529,544$24.1M25.0%Plan not statedSEC
Apr 15, 2015AERIE PHARMACEUTICALS INCDirectorForm 4 sale425,000$14.3M47.5%UnusualSEC
Nov 25, 2014AERIE PHARMACEUTICALS INCDirectorForm 4 sale800,000$20.8M51.1%UnusualSEC
Jul 10, 2014AERIE PHARMACEUTICALS INC10% ownerForm 4 sale1M$24.2M100.0%UnusualSEC